JP2023513487A5 - - Google Patents
Info
- Publication number
- JP2023513487A5 JP2023513487A5 JP2022547042A JP2022547042A JP2023513487A5 JP 2023513487 A5 JP2023513487 A5 JP 2023513487A5 JP 2022547042 A JP2022547042 A JP 2022547042A JP 2022547042 A JP2022547042 A JP 2022547042A JP 2023513487 A5 JP2023513487 A5 JP 2023513487A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- seq
- raav
- human
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062969142P | 2020-02-02 | 2020-02-02 | |
| US62/969,142 | 2020-02-02 | ||
| US202063007297P | 2020-04-08 | 2020-04-08 | |
| US63/007,297 | 2020-04-08 | ||
| US202063063119P | 2020-08-07 | 2020-08-07 | |
| US63/063,119 | 2020-08-07 | ||
| PCT/US2021/015988 WO2021155337A1 (en) | 2020-02-02 | 2021-02-01 | Compositions useful for treating gm1 gangliosidosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023513487A JP2023513487A (ja) | 2023-03-31 |
| JP2023513487A5 true JP2023513487A5 (OSRAM) | 2024-02-08 |
Family
ID=74867612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022547042A Pending JP2023513487A (ja) | 2020-02-02 | 2021-02-01 | Ｇｍ１ガングリオシドーシスを治療するのに有用な組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230190966A1 (OSRAM) |
| EP (1) | EP4096721A1 (OSRAM) |
| JP (1) | JP2023513487A (OSRAM) |
| KR (1) | KR20220145838A (OSRAM) |
| CN (1) | CN115867323A (OSRAM) |
| AU (1) | AU2021213826A1 (OSRAM) |
| BR (1) | BR112022013914A2 (OSRAM) |
| CA (1) | CA3165057A1 (OSRAM) |
| IL (1) | IL294924A (OSRAM) |
| MX (1) | MX2022009462A (OSRAM) |
| TW (1) | TWI905145B (OSRAM) |
| WO (1) | WO2021155337A1 (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021006060A2 (pt) | 2018-10-01 | 2021-07-20 | The Trustees Of The University Of Pennsylvania | composições úteis para tratamento de gangliosidose gm1 |
| WO2023147351A1 (en) * | 2022-01-25 | 2023-08-03 | Regents Of The University Of Minnesota | Crispr-mediated human genome editing with vectors |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10202108118RA (en) | 2001-11-13 | 2021-08-30 | Univ Pennsylvania | A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| US8005620B2 (en) | 2003-08-01 | 2011-08-23 | Dna Twopointo Inc. | Systems and methods for biopolymer engineering |
| WO2005013090A2 (en) | 2003-08-01 | 2005-02-10 | Dna Twopointo Inc. | Systems and methods for biopolymer engineering |
| HUE054805T2 (hu) | 2003-09-30 | 2021-09-28 | Univ Pennsylvania | Adeno-asszociált vírus (AAV) kládok, szekvenciák, az azokat tartalmazó vektorok és alkalmazásaik |
| EP3085389A1 (en) | 2005-04-07 | 2016-10-26 | The Trustees Of The University Of Pennsylvania | Method of increasing the function of an aav vector |
| WO2007120542A2 (en) | 2006-03-30 | 2007-10-25 | The Board Of Trustees Of The Leland Stanford Junior University | Aav capsid library and aav capsid proteins |
| WO2010138263A2 (en) | 2009-05-28 | 2010-12-02 | University Of Massachusetts | Novel aav 's and uses thereof |
| KR20130040844A (ko) | 2010-03-29 | 2013-04-24 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 약학적으로 유발된 전이유전자 제거 시스템 |
| US8927514B2 (en) | 2010-04-30 | 2015-01-06 | City Of Hope | Recombinant adeno-associated vectors for targeted treatment |
| FR2977562B1 (fr) | 2011-07-06 | 2016-12-23 | Gaztransport Et Technigaz | Cuve etanche et thermiquement isolante integree dans une structure porteuse |
| WO2015012924A2 (en) | 2013-04-29 | 2015-01-29 | The Trustees Of The University Of Pennsylvania | Tissue preferential codon modified expression cassettes, vectors containing same, and use thereof |
| AU2015320694B2 (en) | 2014-09-24 | 2021-11-11 | City Of Hope | Adeno-associated virus vector variants for high efficiency genome editing and methods thereof |
| US11098286B2 (en) | 2015-12-11 | 2021-08-24 | The Trustees Of The University Of Pennsylvania | Scalable purification method for AAV9 |
| AU2017215211C1 (en) * | 2016-02-03 | 2023-11-16 | The Trustees Of The University Of Pennsylvania | Gene therapy for treating mucopolysaccharidosis type i |
| MX2019010275A (es) * | 2017-02-28 | 2019-10-15 | Univ Pennsylvania | Novedoso vector del subtipo f del virus adenoasociado (aav) y usos de este. |
| EP3794131A4 (en) * | 2018-05-15 | 2022-01-26 | University of Massachusetts | RAAV VECTORS ENCODING FOR LYSOSOMAL BETA-GALACTOSIDASE (GLB1) AND CATHEPSIN A |
| BR112021006060A2 (pt) * | 2018-10-01 | 2021-07-20 | The Trustees Of The University Of Pennsylvania | composições úteis para tratamento de gangliosidose gm1 |
-
2021
- 2021-02-01 CA CA3165057A patent/CA3165057A1/en active Pending
- 2021-02-01 BR BR112022013914A patent/BR112022013914A2/pt unknown
- 2021-02-01 JP JP2022547042A patent/JP2023513487A/ja active Pending
- 2021-02-01 WO PCT/US2021/015988 patent/WO2021155337A1/en not_active Ceased
- 2021-02-01 EP EP21711072.5A patent/EP4096721A1/en active Pending
- 2021-02-01 US US17/759,905 patent/US20230190966A1/en active Pending
- 2021-02-01 KR KR1020227029939A patent/KR20220145838A/ko active Pending
- 2021-02-01 TW TW110103642A patent/TWI905145B/zh active
- 2021-02-01 IL IL294924A patent/IL294924A/en unknown
- 2021-02-01 MX MX2022009462A patent/MX2022009462A/es unknown
- 2021-02-01 CN CN202180025846.9A patent/CN115867323A/zh active Pending
- 2021-02-01 AU AU2021213826A patent/AU2021213826A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021523198A5 (OSRAM) | ||
| JP2022512589A5 (OSRAM) | ||
| JP2005021149A (ja) | アルツハイマー病の治療のための組換えアデノ随伴ウィルスベクター | |
| JP2022523766A5 (OSRAM) | ||
| JP2020526514A5 (OSRAM) | ||
| JP2024517143A5 (OSRAM) | ||
| WO2009052737A1 (en) | Medicament for preventing and controlling alzheimer's disease | |
| JP2024515459A5 (OSRAM) | ||
| JP2014506787A (ja) | シアル酸産生を増加させて、シアル酸に関連した病状を治療する方法および組成物 | |
| JP2022060514A (ja) | ガバペンチノイドからの干渉が減少し、ｈｇｆ異型体を発現するｄｎａコンストラクトを用いる神経病症の治療 | |
| JP7413629B2 (ja) | Ｉｇｆ－１異型体を発現させるｄｎａコンストラクトを用いた神経病症の治療 | |
| JP2022537555A5 (OSRAM) | ||
| JP2022525848A5 (OSRAM) | ||
| JP2025508841A5 (OSRAM) | ||
| JP2025506681A5 (OSRAM) | ||
| WO2022255906A1 (en) | Drug for genetic and gene-cell-based therapy | |
| TW202140791A (zh) | 治療苯酮尿症之方法 | |
| JP2022550954A5 (OSRAM) | ||
| EP3570896B1 (en) | Compositions for reducing sarcolipin expression and preventing and treating muscular dystrophy and cardiomyopathy and methods of use | |
| JP2022523038A (ja) | 遺伝子置換及び抗炎症を介したデュシェンヌ型筋ジストロフィーに対する一段階遺伝子療法 | |
| JP2023526311A5 (OSRAM) | ||
| JP2022518354A5 (OSRAM) | ||
| CN118146318B (zh) | 一种腺相关病毒衣壳蛋白及其用途 | |
| US12630840B2 (en) | One-step gene therapy for Duchenne muscular dystrophy via gene replacement and anti-inflammation | |
| CN116590342A (zh) | 一种aav载体及其应用 |